Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single Arm, Open Label, Phase IV Study to Evaluate Safety and to Describe the Incidence of Major Cardiovascular Events of Ticagrelor in Chinese Patients With Acute Coronary Syndrome(ACS)

NCT01870921 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01870921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01870921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single Arm, Open Label, Phase IV Study to Evaluate Safety and to Describe the Incidence of Major Cardiovascular Events of Ticagrelor in Chinese Patients With Acute Coronary Syndrome(ACS)
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Completed
Start date
June 26, 2013
Completion date
September 30, 2015
Enrollment
2,004 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome